New York City Point-of-Care Network
What’s New in POC STD Testing
Wednesday, June 8, 2005
Roosevelt Hospital 2nd Floor Conference Room
Advancing HIV Prevention thru:
1. Voluntary Testing
2. New methods for dx HIV infection
3. Preventing new infection
4. Reducing prenatal infections
Currently 4 approved rapid HIV tests. 2 waived are:
1. Uni-Gold Recombigen:
2. Ora-Quick Advance
NYSDOH HIV Testing Guidelines
1. Streamline HIV counseling in all settings
1. Integrate sensitive testing in medical care settings
2. Adapt rapid testing
CDC recommendation: A patient with a positive OraQuick test result and a negative EIA confirmatory test result should have a repeat EIA confirmatory test performed within 2-4 weeks.
For information on 2005 Guidelines including revised information and consent forms:
For general and technical information on rapid HIV testing:
NY State Questions:
Bacterial vaginosis (BV) disease overview: a condition where the normal balance of bacteria in the vagina (Lactobacillus sp.) is disrupted and replace by an overgrowth of pathogenic bacteria (Bacteroides spp, Prevotella spp, Gardnerella vaginalis and Mobiluncus spp.)
Complications from untreated BV include increased risk of preterm labor & birth, or low birth weight; Pelvic Inflammatory Disease (PID); increased susceptibility to other STD’s including HIV.
Rapid Diagnosis: Genzyme OSOM BVblue is an enzyme activity test that detects sialidase activity from vaginal swabs. Sialidase is produced by Bacteroides spp, Prevotella spp, Gardnerella vaginalis and Mobiluncus spp
Test principle: Genzyme OSOM BVblue
Trichomoniasis disease overview: a sexually transmitted disease caused by Trichomonas vaginalis. It resides in the lower genital tract of females and urethra and prostate of males.
Complications from untreated trichomoniasis include increased risk of preterm labor & birth; low birth weight; neonatal infection; increased susceptibility of other STD’s including HIV; cervical cancer
Rapid Diagnosis: OSOM Trichomonas Rapid Test (CLIA waived) is an immunochromatogenic assay that uses “lateral flow test stick format” to detect Trichomonas antigens directly from vaginal swabs.
Test Principle: OSOM Trichomonas Rapid Test
Sept. 14, 2005 was selected as next meeting date.